创e Page:JAG1
Summary?
创eID | 182 |
Symbol | JAG1 |
Synonyms | AGS|AHD|AWS|CD339|HJ1|JAGL1 |
Description | jagged 1 |
Reference | MIM:601920|HGNC:HGNC:6188|Ensembl:ENSG00000101384|HPRD:03562|Vega:OTTHUMG00000031872 |
创e type | protein-coding |
Map location | 20p12.1-p11.23 |
Pascal p-value | 0.311 |
Sherlock p-value | 0.29 |
Fetal beta | 0.26 |
DMG | 2 (# studies) |
eGene | Meta |
Support | Ascano FMRP targets |
基因数据urces
创e set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | 创ome-wide Association Study | GWAS | |
DMG:Jaffe_2016 | 创ome-wide DNA methylation analysis | This dataset includes 2,104 probes/CpGs associated with SZ patients (n=108) compared to 136 controls at Bonferroni-adjusted P < 0.05. | 2 |
DMG:Wockner_2014 | 创ome-wide DNA methylation analysis | This dataset includes 4641 differentially methylated probes corresponding to 2929 unique genes between schizophrenia patients (n=24) and controls (n=24). | 2 |
PMID:cooccur | High-throughput literature-search | 系统搜索PubMed co-o基因ccurring with SCZ keywords. A total of 3027 genes were included. | |
GSMA_I | 创ome scan meta-analysis | Psr: 0.046 | |
Expression | Meta-analysis of gene expression | Pvalue: 1.469 | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenias | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 1 |
Section I. Genetics and epigenetics annotation
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg24652271 | 20 | 10654705 | JAG1 | 1.594E-4 | -0.236 | 0.032 | DMG:Wockner_2014 |
cg08402873 | 20 | 10653164 | JAG1 | 4.75E-10 | -0.022 | 8.35E-7 | DMG:Jaffe_2016 |
Section II. Transcriptome annotation
创eral gene expression (GTEx)
创e expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
创e expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
创e | Pearson's Correlation | Spearman's Correlation |
GPR126 | 0.64 | 0.38 |
BCL2 | 0.58 | 0.33 |
CCDC90A | 0.58 | 0.38 |
PCSK9 | 0.58 | 0.37 |
LRCH1 | 0.56 | 0.36 |
AC016138.1 | 0.55 | 0.36 |
CBLB | 0.54 | 0.40 |
SEMA3E | 0.54 | 0.26 |
RNF182 | 0.53 | 0.43 |
KLHL32 | 0.53 | 0.27 |
Top 10 negatively co-expressed genes | ||
创e | Pearson's Correlation | Spearman's Correlation |
AC018755.7 | -0.34 | -0.36 |
NFKBIB | -0.33 | -0.31 |
ATG16L2 | -0.30 | -0.23 |
ASPHD1 | -0.29 | -0.29 |
CCNI2 | -0.29 | -0.30 |
ZNF385A | -0.29 | -0.31 |
AC024575.3 | -0.29 | -0.31 |
HLA-F | -0.28 | -0.30 |
SLC9A3R2 | -0.28 | -0.26 |
MT-CO2 | -0.28 | -0.33 |
Section III. Gene Ontology annotation
Molecular function | 去的术语 | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005112 | Notch binding | IEA | - | |
GO:0005112 | Notch binding | NAS | 9268641 | |
GO:0005509 | calcium ion binding | IEA | - | |
GO:0005509 | calcium ion binding | NAS | - | |
GO:0005515 | protein binding | IEA | - | |
GO:0005198 | structural molecule activity | NAS | 10679295 | |
GO:0008083 | growth factor activity | NAS | 11067884 | |
Biological process | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0007399 | nervous system development | NAS | neurite (GO term level: 5) | 8923452 |
GO:0001525 | angiogenesis | NAS | 8955070 | |
GO:0001709 | cell fate determination | NAS | 9207788 | |
GO:0002011 | morphogenesis of an epithelial sheet | IEA | - | |
GO:0007154 | cell communication | IEA | - | |
GO:0009887 | organ morphogenesis | IEA | - | |
GO:0007275 | multicellular organismal development | NAS | - | |
GO:0042127 | regulation of cell proliferation | NAS | 10329626 | |
GO:0030216 | keratinocyte differentiation | NAS | 12107827 | |
GO:0030334 | regulation of cell migration | NAS | 11549580 | |
GO:0030097 | hemopoiesis | NAS | 10329626 | |
GO:0042491 | auditory receptor cell differentiation | IEA | - | |
GO:0045639 | positive regulation of myeloid cell differentiation | IEA | - | |
GO:0045747 | positive regulation of Notch signaling pathway | IEA | - | |
GO:0045596 | negative regulation of cell differentiation | IEA | - | |
GO:0045445 | myoblast differentiation | NAS | 10329626 | |
GO:0045446 | endothelial cell differentiation | NAS | 10329626 | |
GO:0048839 | inner ear development | IEA | - | |
Cellular component | 去的术语 | Evidence | Neuro keywords | PubMed ID |
GO:0005576 | extracellular region | NAS | 11427524 | |
GO:0005886 | plasma membrane | IEA | - | |
GO:0005887 | integral to plasma membrane | NAS | 11427524 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG NOTCH SIGNALING PATHWAY | 47 | 35 | 所有SZGR 2.0基因通路 |
BIOCARTA PTDINS PATHWAY | 23 | 16 | 所有SZGR 2.0基因通路 |
PID NOTCH PATHWAY | 59 | 49 | 所有SZGR 2.0基因通路 |
PID TAP63 PATHWAY | 54 | 40 | 所有SZGR 2.0基因通路 |
REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 27 | 18 | 所有SZGR 2.0基因通路 |
REACTOME SIGNALING BY NOTCH4 | 12 | 10 | 所有SZGR 2.0基因通路 |
REACTOME SIGNALING BY NOTCH2 | 12 | 10 | 所有SZGR 2.0基因通路 |
REACTOME SIGNALING BY NOTCH1 | 70 | 46 | 所有SZGR 2.0基因通路 |
REACTOME SIGNALING BY NOTCH3 | 12 | 10 | 所有SZGR 2.0基因通路 |
REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | 12 | 8 | 所有SZGR 2.0基因通路 |
REACTOME SIGNALING BY NOTCH | 103 | 64 | 所有SZGR 2.0基因通路 |
ZHOU INFLAMMATORY RESPONSE LIVE UP | 485 | 293 | 所有SZGR 2.0基因通路 |
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP | 177 | 110 | 所有SZGR 2.0基因通路 |
LIU CMYB TARGETS UP | 165 | 106 | 所有SZGR 2.0基因通路 |
LIU VMYB TARGETS UP | 127 | 78 | 所有SZGR 2.0基因通路 |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN | 455 | 304 | 所有SZGR 2.0基因通路 |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN | 460 | 312 | 所有SZGR 2.0基因通路 |
HORIUCHI WTAP TARGETS UP | 306 | 188 | 所有SZGR 2.0基因通路 |
WANG CLIM2 TARGETS DN | 186 | 114 | 所有SZGR 2.0基因通路 |
JAEGER METASTASIS DN | 258 | 141 | 所有SZGR 2.0基因通路 |
DITTMER PTHLH TARGETS UP | 112 | 68 | 所有SZGR 2.0基因通路 |
SENESE HDAC2 TARGETS DN | 133 | 77 | 所有SZGR 2.0基因通路 |
TIEN INTESTINE PROBIOTICS 24HR DN | 214 | 133 | 所有SZGR 2.0基因通路 |
ZHOU INFLAMMATORY RESPONSE FIMA UP | 544 | 308 | 所有SZGR 2.0基因通路 |
ZHOU INFLAMMATORY RESPONSE LPS UP | 431 | 237 | 所有SZGR 2.0基因通路 |
GOZGIT ESR1 TARGETS DN | 781 | 465 | 所有SZGR 2.0基因通路 |
LIU CDX2 TARGETS UP | 36 | 22 | 所有SZGR 2.0基因通路 |
LINDGREN BLADDER CANCER CLUSTER 3 DN | 229 | 142 | 所有SZGR 2.0基因通路 |
MCBRYAN PUBERTAL BREAST 4 5WK DN | 196 | 131 | 所有SZGR 2.0基因通路 |
MCBRYAN PUBERTAL BREAST 6 7WK UP | 197 | 135 | 所有SZGR 2.0基因通路 |
HAMAI APOPTOSIS VIA TRAIL UP | 584 | 356 | 所有SZGR 2.0基因通路 |
MCBRYAN PUBERTAL TGFB1 TARGETS UP | 169 | 127 | 所有SZGR 2.0基因通路 |
KAN RESPONSE TO ARSENIC TRIOXIDE | 123 | 80 | 所有SZGR 2.0基因通路 |
DARWICHE SKIN TUMOR PROMOTER DN | 185 | 115 | 所有SZGR 2.0基因通路 |
DARWICHE PAPILLOMA RISK LOW UP | 162 | 104 | 所有SZGR 2.0基因通路 |
DARWICHE PAPILLOMA RISK HIGH UP | 147 | 101 | 所有SZGR 2.0基因通路 |
DARWICHE SQUAMOUS CELL CARCINOMA UP | 146 | 104 | 所有SZGR 2.0基因通路 |
PEREZ TP63 TARGETS | 355 | 243 | 所有SZGR 2.0基因通路 |
SCHLOSSER SERUM RESPONSE DN | 712 | 443 | 所有SZGR 2.0基因通路 |
LI CISPLATIN RESISTANCE DN | 35 | 20 | 所有SZGR 2.0基因通路 |
SNIJDERS AMPLIFIED IN HEAD AND NECK TUMORS | 37 | 27 | 所有SZGR 2.0基因通路 |
BEGUM TARGETS OF PAX3 FOXO1 FUSION AND PAX3 | 7 | 5 | 所有SZGR 2.0基因通路 |
SASAKI TARGETS OF TP73 AND TP63 | 11 | 7 | 所有SZGR 2.0基因通路 |
HASINA NOL7 TARGETS DN | 13 | 9 | 所有SZGR 2.0基因通路 |
SHETH LIVER CANCER VS TXNIP LOSS PAM5 | 94 | 59 | 所有SZGR 2.0基因通路 |
GROSS HYPOXIA VIA ELK3 DN | 156 | 106 | 所有SZGR 2.0基因通路 |
GROSS HYPOXIA VIA ELK3 AND HIF1A UP | 142 | 104 | 所有SZGR 2.0基因通路 |
NUYTTEN EZH2 TARGETS DN | 1024 | 594 | 所有SZGR 2.0基因通路 |
BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | 637 | 377 | 所有SZGR 2.0基因通路 |
KOYAMA SEMA3B TARGETS DN | 411 | 249 | 所有SZGR 2.0基因通路 |
WU CELL MIGRATION | 184 | 114 | 所有SZGR 2.0基因通路 |
AMIT EGF RESPONSE 120 HELA | 69 | 47 | 所有SZGR 2.0基因通路 |
ONDER CDH1 TARGETS 1 DN | 169 | 102 | 所有SZGR 2.0基因通路 |
ROZANOV MMP14 CORRELATED | 11 | 9 | 所有SZGR 2.0基因通路 |
ROZANOV MMP14 TARGETS UP | 266 | 171 | 所有SZGR 2.0基因通路 |
ROSS AML WITH PML RARA FUSION | 77 | 62 | 所有SZGR 2.0基因通路 |
SHEPARD CRUSH AND BURN MUTANT DN | 185 | 111 | 所有SZGR 2.0基因通路 |
ALCALAY AML BY NPM1 LOCALIZATION UP | 140 | 83 | 所有SZGR 2.0基因通路 |
VERHAAK AML WITH NPM1 MUTATED UP | 183 | 111 | 所有SZGR 2.0基因通路 |
SESTO RESPONSE TO UV C2 | 54 | 39 | 所有SZGR 2.0基因通路 |
SESTO RESPONSE TO UV C5 | 46 | 36 | 所有SZGR 2.0基因通路 |
WANG SMARCE1 TARGETS UP | 280 | 183 | 所有SZGR 2.0基因通路 |
MARTINEZ RESPONSE TO TRABECTEDIN DN | 271 | 175 | 所有SZGR 2.0基因通路 |
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP | 953 | 554 | 所有SZGR 2.0基因通路 |
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP | 783 | 442 | 所有SZGR 2.0基因通路 |
FOSTER TOLERANT MACROPHAGE UP | 156 | 92 | 所有SZGR 2.0基因通路 |
海勒HDAC目标被甲基化 | 461 | 298 | 所有SZGR 2.0基因通路 |
MASSARWEH TAMOXIFEN RESISTANCE UP | 578 | 341 | 所有SZGR 2.0基因通路 |
RIZKI TUMOR INVASIVENESS 3D DN | 270 | 181 | 所有SZGR 2.0基因通路 |
RIGGI EWING SARCOMA PROGENITOR UP | 430 | 288 | 所有SZGR 2.0基因通路 |
HUANG FOXA2 TARGETS UP | 45 | 28 | 所有SZGR 2.0基因通路 |
IZADPANAH STEM CELL ADIPOSE VS BONE UP | 126 | 92 | 所有SZGR 2.0基因通路 |
ZHENG GLIOBLASTOMA PLASTICITY UP | 250 | 168 | 所有SZGR 2.0基因通路 |
LABBE TGFB1 TARGETS UP | 102 | 64 | 所有SZGR 2.0基因通路 |
LABBE TARGETS OF TGFB1 AND WNT3A UP | 111 | 70 | 所有SZGR 2.0基因通路 |
WEST ADRENOCORTICAL TUMOR UP | 294 | 199 | 所有SZGR 2.0基因通路 |
CLIMENT BREAST CANCER COPY NUMBER UP | 23 | 20 | 所有SZGR 2.0基因通路 |
LU TUMOR ANGIOGENESIS UP | 25 | 22 | 所有SZGR 2.0基因通路 |
LIN TUMOR ESCAPE FROM IMMUNE ATTACK | 18 | 12 | 所有SZGR 2.0基因通路 |
HUANG DASATINIB RESISTANCE UP | 81 | 53 | 所有SZGR 2.0基因通路 |
HUPER BREAST BASAL VS LUMINAL UP | 54 | 29 | 所有SZGR 2.0基因通路 |
JIANG TIP30 TARGETS UP | 46 | 28 | 所有SZGR 2.0基因通路 |
VART KSHV INFECTION ANGIOGENIC MARKERS UP | 165 | 118 | 所有SZGR 2.0基因通路 |
YOSHIMURA MAPK8 TARGETS DN | 366 | 257 | 所有SZGR 2.0基因通路 |
RUTELLA RESPONSE TO CSF2RB AND IL4 UP | 338 | 225 | 所有SZGR 2.0基因通路 |
RUTELLA RESPONSE TO HGF UP | 418 | 282 | 所有SZGR 2.0基因通路 |
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN | 245 | 150 | 所有SZGR 2.0基因通路 |
CHANG CORE SERUM RESPONSE DN | 209 | 137 | 所有SZGR 2.0基因通路 |
BRUNEAU HEART GREAT VESSELS AND VALVULOGENESIS | 8 | 8 | 所有SZGR 2.0基因通路 |
MEISSNER BRAIN HCP WITH H3K4ME3 AND H3K27ME3 | 1069 | 729 | 所有SZGR 2.0基因通路 |
ZHAN LATE DIFFERENTIATION GENES UP | 33 | 24 | 所有SZGR 2.0基因通路 |
VALK AML CLUSTER 2 | 29 | 14 | 所有SZGR 2.0基因通路 |
COULOUARN TEMPORAL TGFB1 SIGNATURE DN | 138 | 99 | 所有SZGR 2.0基因通路 |
WOO LIVER CANCER RECURRENCE UP | 105 | 75 | 所有SZGR 2.0基因通路 |
SCHOEN NFKB SIGNALING | 34 | 26 | 所有SZGR 2.0基因通路 |
VERHAAK GLIOBLASTOMA CLASSICAL | 162 | 122 | 所有SZGR 2.0基因通路 |
CHICAS RB1 TARGETS CONFLUENT | 567 | 365 | 所有SZGR 2.0基因通路 |
FUKUSHIMA TNFSF11 TARGETS | 16 | 14 | 所有SZGR 2.0基因通路 |
JOHNSTONE PARVB TARGETS 3 UP | 430 | 288 | 所有SZGR 2.0基因通路 |
MIYAGAWA TARGETS OF EWSR1 ETS FUSIONS UP | 259 | 159 | 所有SZGR 2.0基因通路 |
PASINI SUZ12 TARGETS DN | 315 | 215 | 所有SZGR 2.0基因通路 |
AZARE NEOPLASTIC TRANSFORMATION BY STAT3 UP | 121 | 70 | 所有SZGR 2.0基因通路 |
LEE BMP2 TARGETS UP | 745 | 475 | 所有SZGR 2.0基因通路 |
WINZEN DEGRADED VIA KHSRP | 100 | 70 | 所有SZGR 2.0基因通路 |
IKEDA MIR1 TARGETS UP | 53 | 39 | 所有SZGR 2.0基因通路 |
PEDERSEN METASTASIS BY ERBB2 ISOFORM 7 | 403 | 240 | 所有SZGR 2.0基因通路 |
PLASARI TGFB1 TARGETS 10HR UP | 199 | 143 | 所有SZGR 2.0基因通路 |
LIU IL13 PRIMING MODEL | 15 | 11 | 所有SZGR 2.0基因通路 |
PHONG TNF RESPONSE VIA P38 COMPLETE | 227 | 151 | 所有SZGR 2.0基因通路 |
PECE MAMMARY STEM CELL UP | 146 | 75 | 所有SZGR 2.0基因通路 |
PECE MAMMARY STEM CELL DN | 146 | 88 | 所有SZGR 2.0基因通路 |
LIM MAMMARY STEM CELL UP | 489 | 314 | 所有SZGR 2.0基因通路 |
ZWANG CLASS 3 TRANSIENTLY INDUCED BY EGF | 222 | 159 | 所有SZGR 2.0基因通路 |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-124.1 | 1309 | 1316 | 1A,m8 | hsa-miR-124a | UUAAGGCACGCGGUGAAUGCCA |
hsa-miR-124a | UUAAGGCACGCGGUGAAUGCCA | ||||
miR-124/506 | 1309 | 1315 | 1A | hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA |
hsa-miR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA | ||||
hsa-miR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
miR-129-5p | 196 | 202 | m8 | hsa-miR-129brain | CUUUUUGCGGUCUGGGCUUGC |
hsa-miR-129-5p | CUUUUUGCGGUCUGGGCUUGCU | ||||
miR-140 | 443 | 449 | 1A | hsa-miR-140brain | AGUGGUUUUACCCUAUGGUAG |
miR-141/200a | 1428 | 1434 | 1A | hsa-miR-141 | UAACACUGUCUGGUAAAGAUGG |
hsa-miR-200a | UAACACUGUCUGGUAACGAUGU | ||||
miR-153 | 192 | 199 | 1A,m8 | hsa-miR-153 | UUGCAUAGUCACAAAAGUGA |
miR-186 | 601 | 607 | m8 | hsa-miR-186 | CAAAGAAUUCUCCUUUUGGGCUU |
miR-21 | 1234 | 1241 | 1A,m8 | hsa-miR-21brain | UAGCUUAUCAGACUGAUGUUGA |
hsa-miR-590 | GAGCUUAUUCAUAAAAGUGCAG | ||||
miR-224 | 90 | 96 | 1A | hsa-miR-224 | CAAGUCACUAGUGGUUCCGUUUA |
miR-26 | 1248 | 1255 | 1A,m8 | hsa-miR-26abrain | UUCAAGUAAUCCAGGAUAGGC |
hsa-miR-26bSZ | UUCAAGUAAUUCAGGAUAGGUU | ||||
hsa-miR-26abrain | UUCAAGUAAUCCAGGAUAGGC | ||||
hsa-miR-26bSZ | UUCAAGUAAUUCAGGAUAGGUU | ||||
miR-335 | 365 | 371 | 1A | hsa-miR-335brain | UCAAGAGCAAUAACGAAAAAUGU |
miR-34/449 | 1302 | 1308 | m8 | hsa-miR-34abrain | UGGCAGUGUCUUAGCUGGUUGUU |
hsa-miR-34c | AGGCAGUGUAGUUAGCUGAUUGC | ||||
hsa-miR-449 | UGGCAGUGUAUUGUUAGCUGGU | ||||
hsa-miR-449b | AGGCAGUGUAUUGUUAGCUGGC | ||||
miR-34b | 1303 | 1309 | m8 | hsa-miR-34b | UAGGCAGUGUCAUUAGCUGAUUG |
miR-377 | 1105 | 1112 | 1A,m8 | hsa-miR-377 | AUCACACAAAGGCAACUUUUGU |
hsa-miR-377 | AUCACACAAAGGCAACUUUUGU | ||||
miR-381 | 379 | 385 | 1A | hsa-miR-381 | UAUACAAGGGCAAGCUCUCUGU |
hsa-miR-381 | UAUACAAGGGCAAGCUCUCUGU | ||||
miR-421 | 921 | 927 | 1A | hsa-miR-421 | GGCCUCAUUAAAUGUUUGUUG |
miR-448 | 193 | 199 | 1A | hsa-miR-448 | UUGCAUAUGUAGGAUGUCCCAU |
miR-450 | 196 | 202 | 1A | hsa-miR-450 | UUUUUGCGAUGUGUUCCUAAUA |
miR-485-3p | 1511 | 1518 | 1A,m8 | hsa-miR-485-3p | GUCAUACACGGCUCUCCUCUCU |
miR-496 | 592 | 598 | 1A | hsa-miR-496 | AUUACAUGGCCAAUCUC |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Clickhereto see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Clickhereto see the list of brain related miRNAs.